Growth of drug resistant HIV in China is “worrying,” says AIDS instituteBMJ 2008; 337 doi: http://dx.doi.org/10.1136/bmj.a2197 (Published 22 October 2008) Cite this as: BMJ 2008;337:a2197
- Jane Parry
- 1Hong Kong
Resistance of HIV to drugs is increasing in China, Zhiwei Chen, director of the University of Hong Kong’s AIDS Institute, has said. Only seven of the more than 20 antiretroviral drugs on the market are available in China.
“The drug resistant mutations are not unique to Chinese people and therefore are consistent with those found in other countries,” he said. “However, the frequency of drug resistance after two years of treatment is high. The unique feature is that a significant portion of treated patients have developed AIDS due to the drug resistant mutations and the lack of second line drugs.”
At the same time, he said, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial